Coagulation and immune function indicators for monitoring of coronavirus disease 2019 and the clinical significance.
10.11817/j.issn.1672-7347.2020.200314
- Author:
Junhua ZHANG
1
;
Tie LI
2
;
Rong HUANG
3
;
Rong GUI
4
;
Sai CHEN
5
Author Information
1. Department of Blood Transfusion, Third Xiangya Hospital, Central South University, Changsha 410013. xy3zhangjunhua@csu.edu.cn.
2. Department of Laboratory Medicine, First People's Hospital of Yueyang, Yueyang Hunan 414000, China.
3. Department of Blood Transfusion, Third Xiangya Hospital, Central South University, Changsha 410013.
4. Department of Blood Transfusion, Third Xiangya Hospital, Central South University, Changsha 410013. aguirong@163.com.
5. Department of Blood Transfusion, Third Xiangya Hospital, Central South University, Changsha 410013. 1754142340@qq.com.
- Publication Type:Journal Article
- Keywords:
coagulation function;
coronavirus disease 2019;
immune function;
pneumonia
- MeSH:
Aged;
Betacoronavirus;
Blood Coagulation;
China;
Coronavirus Infections;
diagnosis;
immunology;
Humans;
Immune System;
physiopathology;
Middle Aged;
Pandemics;
Pneumonia, Viral;
diagnosis;
immunology
- From:
Journal of Central South University(Medical Sciences)
2020;45(5):525-529
- CountryChina
- Language:English
-
Abstract:
OBJECTIVES:To explore the significance of coagulation and immune function indicators in clinical diagnosis and treatment of coronavirus disease 2019 (COVID-19).
METHODS:All patients with COVID-19 diagnosed and treated in First People's Hospital of Yueyang from January to March 2020 were enrolled. The general data of patients were collected. The patients were assigned into a light group (=20), an ordinary group (=33), a severe group (=23), and a critically severe group (=7) according to the severity of the disease. Coagulation and immune function indicators of each group were compared, and the relevance of coagulation and immune function indicators was analyzed.
RESULTS:The age of COVID-19 patients in Yueyang City was mainly between 45 and 65 years old. There was a significant difference in the coagulation function and immune-related indicators in each group of patients (all <0.05).
CONCLUSIONS:There are some abnormalities in coagulation and immune function in patients with COVID-19, which possess significance for clinical diagnosis and treatment of the disease.
